Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery

NCT00198445 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

527

Enrollment

INDUSTRY

Sponsor class

Conditions

Postoperative Complications
Cataract

Interventions

DRUG: Bromfenac
DRUG: Placebo

Sponsor

Bausch & Lomb Incorporated